Efficacy and safety of meropenem (3Â g daily) in Japanese patients with refractory respiratory infections

Treatment with MEPM (3 g daily) in Japanese patients with refractory pneumonia and/or intrapleural infections is effective, with sufficient plasma concentrations of MEPM, and the treatment has a relatively good safety profile.